Tabla descriptiva 4 grupos: profx, tto, up, down.

Comparativa segun dosis HBPM primeras 48h UCI y su evolucion
n 269 462 40 11
DD (median [IQR]) 2185.50 [800.00, 5932.50] 2029.00 [933.25, 7629.00] 7679.00 [1345.00, 14560.00] 6069.50 [1533.75, 17146.50] 0.392
age (median [IQR]) 63.00 [56.00, 71.00] 63.50 [56.00, 71.00] 66.00 [58.00, 72.00] 66.00 [64.00, 71.00] 0.235
sex = mujer (%) 92 (34.3) 149 (32.4) 10 (25.0) 2 ( 18.2) 0.214
diasdesint_hosp (median [IQR]) 7.00 [5.00, 9.00] 7.00 [5.00, 9.00] 7.00 [4.00, 9.00] 7.00 [5.25, 8.75] 0.069
diasdesint_uci (median [IQR]) 9.00 [7.00, 13.00] 10.00 [7.00, 13.00] 9.50 [7.00, 12.25] 9.00 [8.50, 10.00] 0.181
apache (mean (SD)) 19.09 (29.19) 18.33 (29.98) 21.47 (37.11) 18.57 (10.08) 0.055
sofa (mean (SD)) 6.98 (3.11) 7.14 (3.36) 6.59 (2.86) 7.50 (2.20) 0.173
curb (mean (SD)) 1.92 (1.10) 2.13 (1.22) 1.91 (0.97) 2.57 (1.51) 0.287
pafi3 (%) 0.497
(41,100] 26 (10.5) 71 (15.9) 8 (20.5) 0 ( 0.0)
(100,200] 146 (58.9) 227 (50.8) 25 (64.1) 5 ( 62.5)
(200,486] 76 (30.6) 149 (33.3) 6 (15.4) 3 ( 37.5)
ferritina (median [IQR]) 1519.00 [794.00, 3714.00] 1613.00 [907.00, 3654.50] 3601.00 [1210.00, 9764.00] 1694.00 [1118.50, 2033.00] 0.223
pcr (median [IQR]) 19.87 [10.02, 56.50] 44.75 [16.22, 196.00] 21.75 [12.09, 35.08] 23.05 [10.74, 30.74] 0.353
linfocito (mean (SD)) 0.88 (0.78) 1.02 (1.15) 0.82 (0.43) 1.19 (0.92) 0.254
ratio_pcrlinf (median [IQR]) 31.10 [13.30, 80.81] 66.67 [17.56, 254.75] 28.29 [13.11, 86.23] 24.02 [10.86, 42.73] 0.334
ilk6 (median [IQR]) 866.00 [133.50, 1847.00] 448.00 [167.00, 1725.00] 347.00 [173.50, 441.50] NA [NA, NA] NA
plaq (mean (SD)) 566.03 (853.28) 1223.34 (11123.26) 746.19 (1290.38) 620.82 (833.32) 0.094
ventm = si (%) 212 (78.8) 423 (91.6) 35 (87.5) 11 (100.0) 0.405
hf_1intencion = si (%) 14 ( 5.2) 15 ( 3.2) 2 ( 5.0) 0 ( 0.0) 0.185
man_reclutamiento = si (%) 133 (49.4) 297 (64.3) 25 (62.5) 4 ( 36.4) 0.333
prono = si (%) 170 (63.2) 355 (76.8) 32 (80.0) 9 ( 81.8) 0.226
ttoreljmusc = si (%) 169 (62.8) 347 (75.1) 32 (80.0) 10 ( 90.9) 0.370
ecmo = si (%) 3 ( 1.1) 7 ( 1.5) 1 ( 2.5) 0 ( 0.0) 0.127
elim_extraco2r = si (%) 5 ( 1.9) 9 ( 1.9) 1 ( 2.5) 0 ( 0.0) 0.118
rempl_renal = si (%) 26 ( 9.7) 61 (13.2) 6 (15.0) 1 ( 9.1) 0.110
aclara_creatinina (median [IQR]) 90.00 [41.29, 90.00] 49.50 [1.35, 90.00] 1.05 [0.98, 1.23] 60.10 [60.10, 60.10] NA
lap_ritonavir = si (%) 155 (57.6) 278 (60.2) 19 (47.5) 7 ( 63.6) 0.173
cloroquina = si (%) 232 (86.2) 415 (89.8) 37 (92.5) 10 ( 90.9) 0.108
rendesivir = si (%) 7 ( 2.6) 14 ( 3.0) 1 ( 2.5) 0 ( 0.0) 0.129
interf = si (%) 53 (19.7) 119 (25.8) 8 (20.0) 0 ( 0.0) 0.422
tozi = si (%) 112 (41.6) 227 (49.1) 21 (52.5) 4 ( 36.4) 0.189
azitro = si (%) 204 (75.8) 341 (73.8) 31 (77.5) 8 ( 72.7) 0.063
corticoides = si (%) 210 (78.1) 375 (81.2) 36 (90.0) 8 ( 72.7) 0.240
ttovascular = si (%) 261 (97.0) 453 (98.1) 39 (97.5) 11 (100.0) 0.134
ttoneo = si (%) 33 (12.3) 39 ( 8.4) 4 (10.0) 1 ( 9.1) 0.068
ttoacoag = si (%) 18 ( 6.7) 27 ( 5.8) 3 ( 7.5) 0 ( 0.0) 0.211
complica_hemo = TRUE (%) 29 (10.8) 49 (10.6) 6 (15.0) 2 ( 18.2) 0.130
complica_trombe = TRUE (%) 22 ( 8.2) 49 (10.6) 7 (17.5) 0 ( 0.0) 0.354
muere = si (%) 70 (26.0) 162 (35.1) 13 (32.5) 5 ( 45.5) 0.215

Mortalidad, tto vs profilaxis:

Mortalidad, Odds Ratio (sexo, edad, log(DD), 2 grupos dosis)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 1.52 [1.03;2.22] 0.0332482
age 1.04 [1.02;1.05] 0.0001748
log(DD) 1.38 [1.19;1.61] < 1e-04
grupo profilaxis Ref
tto 1.71 [1.15;2.53] 0.0074758
Mortalidad, Odds Ratio (sexo, edad, log(DD), sofa, 2 grupos dosis, sofa)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 1.65 [1.06;2.57] 0.0269995
age 1.04 [1.02;1.06] 0.0004493
log(DD) 1.40 [1.17;1.69] 0.0003255
grupo profilaxis Ref
tto 1.40 [0.89;2.19] 0.1453912
sofa 1.10 [1.04;1.18] 0.0025395
Mortalidad, Odds Ratio (sexo, edad, log(DD), sofa, prono, 2 grupos dosis)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 1.68 [1.07;2.64] 0.0243013
age 1.04 [1.02;1.07] 0.0001694
log(DD) 1.37 [1.14;1.65] 0.0008897
sofa 1.11 [1.04;1.19] 0.0016308
prono no Ref
si 2.97 [1.71;5.15] 0.0001138
grupo profilaxis Ref
tto 1.16 [0.73;1.85] 0.5291130
Mortalidad, Odds Ratio (sexo, edad, log(DD),sofa, prono, corticoides, 2 grupos dosis)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 1.68 [1.08;2.62] 0.0226995
age 1.04 [1.02;1.06] 0.0007524
log(DD) 1.39 [1.16;1.67] 0.0004836
sofa 1.11 [1.04;1.19] 0.0013531
corticoides no Ref
si 1.87 [0.93;3.75] 0.0794030
grupo profilaxis Ref
tto 1.34 [0.85;2.11] 0.2016193

Complicaciones tromboticas:

Complicaciones trombotica, Odds Ratio (sexo, edad, log(DD), 2 grupos dosis)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 0.32 [0.15;0.70] 0.004306
age 1.00 [0.97;1.03] 0.963658
log(DD) 1.44 [1.14;1.81] 0.002047
grupo profilaxis Ref
tto 1.14 [0.63;2.07] 0.669254

Complicaciones hemorragicas:

Complicaciones hemorragicas, Odds Ratio (sexo, edad, log(DD), 2 grupos dosis)
Variable Units OddsRatio CI.95 p-value
sex hombre Ref
mujer 0.79 [0.45;1.40] 0.41735
age 1.03 [1.00;1.06] 0.02676
log(DD) 1.25 [1.01;1.55] 0.03814
grupo profilaxis Ref
tto 1.07 [0.62;1.86] 0.79569